Heartflow Completes Convertible Notes Financing

King & Spalding represented Heartflow, the leader in AI technology for coronary artery disease, in securing additional investment through the sale and issuance of convertible notes. This financing included new investment from Fidelity Management & Research Company, as well as additional investments from existing investors. A link to the press release detailing the financing can be found here.